Prenatal diagnosis and genetic counseling of 20 fetuses with 15q11.2 BP1-BP2 microdeletion syndrome.
10.3760/cma.j.cn511374-20240808-00429
- Author:
Meijuan LI
1
,
2
;
Xinyou YU
;
Lanhua YANG
;
Xiaoyan WANG
;
Bo WEI
Author Information
1. General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China. weibo2018007@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Female;
Pregnancy;
Chromosomes, Human, Pair 15/genetics*;
Genetic Counseling;
Prenatal Diagnosis;
Chromosome Deletion;
Adult;
Fetus/abnormalities*;
Retrospective Studies;
Pregnancy Outcome;
Ultrasonography, Prenatal;
Genetic Testing;
DiGeorge Syndrome/diagnosis*;
Male
- From:
Chinese Journal of Medical Genetics
2025;42(1):64-68
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinical phenotype, pregnancy outcome and follow-up of fetuses with 15q11.2BP1-BP2 microdeletions in order to provide a basis for prenatal and reproductive consultation.
METHODS:From March 2019 to December 2023, 20 fetuses who were diagnosed with 15q11.2BP1-BP2 microdeletion syndrome at the Prenatal Diagnosis Center of General Hospital of Ningxia Medical University were selected as the study subjects. Results of genetic testing and ultrasound examination, outcome of pregnancy, and postnatal follow-up were retrospectively analyzed. This study has been approved by the Ethics Committee of General Hospital of Ningxia Medical University ([2020]0520B).
RESULTS:None of the 20 fetuses was found to have chromosomal abnormality, whilst all were found to harbor a 15q11.2 BP1-BP2 microdeletion by low-depth whole genome sequencing (CNV-seq). The range of deletions was determined as 0.26 ~ 0.87 Mb, and all were rated as pathogenic CNVs. Three fetuses had abnormal ultrasound findings, including 1 with widened renal pelvis, 1 with agenesis of corpus callosum, and 1 with nuchal fold thickening. Parental verification in 10 couples verified that two fetal deletions were de novo, whilst the remaining eight were inherited from a phenotypically normal parent. Following genetic counseling, three couples had opted to terminate the pregnancy, whilst the remaining 17 had continued with the pregnancy until delivery. The 17 liveborns were followed up for 2 months to 5 years, with no obvious abnormality in growth and development noted.
CONCLUSION:CNV-seq plays an important role in the prenatal diagnosis of 15q11.2 BP1-BP2 microdeletions. Such deletions may not always lead to disease phenotypes. Individualized consultation and long-term follow-up, in combination with intrauterine ultrasound and parental verification are necessary.
